Affimed N.V. logo
Affimed N.V. AFMD

Quarterly report 2022-Q2
added 08-11-2022

report update icon

Affimed N.V. Long Term Debt Current 2011-2026 | AFMD

Annual Long Term Debt Current Affimed N.V.

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- 492 K 532 K - - - - - - - -

All numbers in EUR currency

Indicator range from annual reports

Maximum Minimum Average
532 K 492 K 512 K

Long Term Debt Current of other stocks in the Biotechnology industry

Issuer Long Term Debt Current Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
3.63 M - 2.43 % $ 254 M germanyGermany
Adagene Adagene
ADAG
1.18 M $ 2.19 7.88 % $ 123 M chinaChina
Acorda Therapeutics Acorda Therapeutics
ACOR
1.59 M - -24.86 % $ 820 K usaUSA
BioLineRx Ltd. BioLineRx Ltd.
BLRX
522 K $ 3.03 2.35 % $ 908 M israelIsrael
BioNTech SE BioNTech SE
BNTX
39.5 M $ 117.93 -0.46 % $ 27.2 B germanyGermany
Aeterna Zentaris Aeterna Zentaris
AEZS
271 K - 5.93 % $ 314 M canadaCanada
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
57.6 K $ 3.31 1.22 % $ 7.96 B australiaAustralia
BioXcel Therapeutics BioXcel Therapeutics
BTAI
374 K $ 1.83 0.83 % $ 4.64 M usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
428 K - -10.17 % $ 12.2 K usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
43 K $ 4.23 1.68 % $ 9.2 B israelIsrael
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
625 K - - $ 1.01 B usaUSA
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
6.8 M $ 26.09 -0.21 % $ 1.26 B usaUSA
Coherus BioSciences Coherus BioSciences
CHRS
1.42 M $ 2.03 27.67 % $ 191 M usaUSA
Aptose Biosciences Aptose Biosciences
APTO
428 K - -45.71 % $ 1.2 M canadaCanada
Aravive Aravive
ARAV
2.2 M - -13.39 % $ 1.45 M usaUSA
Athira Pharma Athira Pharma
ATHA
414 K - - $ 269 M usaUSA
Akouos Akouos
AKUS
671 K - 0.23 % $ 488 M usaUSA
AVROBIO AVROBIO
AVRO
878 K - 1083.1 % $ 745 M usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
4.64 M - - $ 10.1 M usaUSA
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
14.2 M $ 230.76 0.92 % $ 5 B danmarkDanmark
ARCA biopharma ARCA biopharma
ABIO
213 K - 1052.0 % $ 415 M usaUSA
Aytu BioScience Aytu BioScience
AYTU
137 K $ 2.72 0.37 % $ 17.1 M usaUSA
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
CORT
829 K $ 42.02 1.74 % $ 4.34 B usaUSA
Acasti Pharma Acasti Pharma
ACST
75 K - 4.01 % $ 150 M canadaCanada
Catalyst Pharmaceuticals Catalyst Pharmaceuticals
CPRX
402 K $ 24.23 -0.9 % $ 2.87 B usaUSA
Arrowhead Pharmaceuticals Arrowhead Pharmaceuticals
ARWR
7.29 M $ 70.82 1.77 % $ 9.47 B usaUSA
Brickell Biotech Brickell Biotech
BBI
49 K - -5.38 % $ 6.06 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
17.6 M - 0.49 % $ 251 B cayman-islandsCayman-islands
Champions Oncology Champions Oncology
CSBR
1.47 M $ 6.9 -0.43 % $ 94.3 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
419 K - - $ 7.46 M israelIsrael
Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc
ADAP
5.38 M - -15.15 % $ 60.3 M britainBritain
AIkido Pharma AIkido Pharma
AIKI
410 K - 1.93 % $ 17.4 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
3.08 M - -0.23 % $ 916 M usaUSA
CureVac N.V. CureVac N.V.
CVAC
3.47 M - - $ 867 M germanyGermany
Acer Therapeutics Acer Therapeutics
ACER
104 K - 2.71 % $ 14 M usaUSA
Bellicum Pharmaceuticals Bellicum Pharmaceuticals
BLCM
11 M - -9.72 % $ 5.89 M usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
756 K - - $ 2.17 B usaUSA
AlloVir AlloVir
ALVR
10.8 M - 4.14 % $ 49.1 M usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
274 K - -11.43 % $ 502 K usaUSA
Biogen Biogen
BIIB
86.4 M $ 171.66 -1.23 % $ 25 B usaUSA
Bio-Path Holdings Bio-Path Holdings
BPTH
103 K - - $ 100 K usaUSA
BioVie BioVie
BIVI
74.5 K $ 1.26 0.79 % $ 1.86 M usaUSA
Baudax Bio Baudax Bio
BXRX
5.6 M - 0.59 % $ 63 K usaUSA